Dr Reddys Laboratories (RDY) Goodwill (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Goodwill of $135.8 million for Q2 2026, down 3.69% on a QoQ basis from $141.0 million in Q1 2026, and down 2.92% year-over-year from $139.9 million in Q2 2025.
Analysis
Dr Reddys Laboratories (RDY) Goodwill (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories has reported Goodwill for 18 years, with the latest figure at $135.8 million in Q2 2026.
- On a quarterly basis, Goodwill fell 2.92% year-over-year to $135.8 million in Q2 2026; TTM through Jun 2026 was $135.8 million, a 2.92% decrease from a year earlier, with the FY2026 full-year figure at $137.0 million, down 0.72% from the prior year.
- Goodwill was $135.8 million for Q2 2026 at Dr Reddys Laboratories, down from $141.0 million in the prior quarter.
- The five-year high for Goodwill was $141.0 million in Q1 2026, with the low at $50.9 million in Q2 2024.
- Average Goodwill over 5 years is $91.5 million, with a median of $57.8 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Goodwill decreased 12.11% in 2023, then surged 175.15% in 2024.
- Over 5 years, Goodwill stood at $54.7 million in 2022, then decreased by 5.96% to $51.5 million in 2023, then surged by 172.71% to $140.4 million in 2024, then dropped by 0.75% to $139.4 million in 2025, then retreated by 2.53% to $135.8 million in 2026.
- The last three Goodwill figures came in at $135.8 million (Q2 2026), $141.0 million (Q1 2026), and $139.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 518.87 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 405.56 Mn | 364.31 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 135.84 Mn |
| Mar 31, 2026 | 141.04 Mn |
| Dec 31, 2025 | 139.36 Mn |
| Sep 30, 2025 | 140.99 Mn |
| Jun 30, 2025 | 139.92 Mn |
| Mar 31, 2025 | 136.38 Mn |
| Dec 31, 2024 | 140.41 Mn |
| Sep 30, 2024 | 140.56 Mn |
| Jun 30, 2024 | 50.86 Mn |
| Mar 31, 2024 | 51.21 Mn |
| Dec 31, 2023 | 51.49 Mn |
| Sep 30, 2023 | 51.09 Mn |
| Jun 30, 2023 | 51.58 Mn |
| Mar 31, 2023 | 51.64 Mn |
| Dec 31, 2022 | 54.75 Mn |
| Sep 30, 2022 | 54.29 Mn |
| Jun 30, 2022 | 56.81 Mn |
| Mar 31, 2022 | 58.76 Mn |
| Dec 31, 2021 | 60.67 Mn |
| Sep 30, 2021 | 61.76 Mn |